|
International Symposium on Hybrid Imaging and Theranostics
Programme
|
|
|
Thursday, October 16, 2025 |
| 08:30-17:00 |
Registration |
| 09:00-09:15 |
Vera Artiko, Dragana Šobić Šaranović Welcome |
| 1 |
Imaging in Nuclear Medicine |
|
Chairpersons: Dragana Šobić Šaranović, Marija Šišić |
| 09:15-09:30 |
Raluca Mititelu |
Nuclear medicine in diagnosis of amyloidosis/Nuklearna medicina u dijagnostici amiloidoze |
| 09:30-09:45 |
Veljko Crnobrnja |
Diagnosis of amyloidosis KC Vojvodine/Dijagnoza amiloidoze u KC Vojvodine |
| 09:45-10:00 |
Marija Šišić |
Advantages of SPECT/CT in diagnosis of cardiac amyloidosis/Prednosti SPECT/CT-a u dijagnostici kardijalne amiloidoze |
| 10:00-10:15 |
Discussion |
|
| 10:15-10:30 |
Coffee break |
| 10:30-11:00 |
Symposium Pfizer |
| 10:30-10:40 |
Ivan Stanković |
The evolution of ATTR-CM management: why, how early and when is it early enough to diagnose? |
| 10:40-10:50 |
Dragana Šobić Šaranović |
Cardiac scintigraphy in diagnosis of ATTR-
CM: reliability, dilemmas and pitfalls? |
| 10:50-11:00 |
Discussion |
|
| 2 |
Technological advances in Nuclear Medicine |
|
Chairpersons: Marcus Hacker, Strahinja Odalović |
| 11:15-11:30 |
Marcus Hacker |
PET/MRI and PET/CT in primary prostate cancer/PET/MRI i PET/CT u primarnom karcinomu prostate |
| 11:30-11:45 |
Markus Diemling |
Dosimetry in Nuclear Medicine Therapy/Dozimetrija u radionukldinoj terapiji |
| 11:45-12:00 |
Marko Grahovac |
AI in nuclear medicine/Veštačka inteligencija u nuklearnoj medicini |
| 12:00-12:15 |
Nikola Ilić |
Data as a prerequisite for machine learning and artificial intelligence/Podaci kao preduslov za mašinsko učenje i veštačku inteligenciju |
| 12:15-12:30 |
Marina Popović Krneta |
Personalized Management of Papillary Thyroid Cancer: A Machine Learning Approach/Personalizovani pristup terapiji karcinoma štitaste žlezde: mašinsko učenje |
| 12:30-12:45 |
Discussion |
| 12:45-13:45 |
Welcome buffet |
| 13:45-14:15 |
Symposium GE |
|
| 14:15-14.30 |
Satellite Symposium KVARK |
Juan Carlos Maltez, IBA Cyclotron |
| 3 |
Theranostics in Endocrinology |
|
Chairpersons: Vera Artiko, Miloš Žarković, Jasna Mihailović |
| 14:30-14:45 |
Miloš Žarković |
The use of contrast in echosonographic diagnosis and therapy of thyroid nodules/Upotreba kontrasta u ehosonografskoj dijagnostici i terapiji tiroidnih nodusa. |
| 14:45-15:00 |
Jasna Mihailović |
Radionuclide threrapy of differentiated thyroid carcinoma/Radionuklidna terapija diferentovanog karcinoma štitaste žlezde |
| 15:00-15:15 |
Sanja Ognjanović |
NET-Therapeutic approach/ Terapijski pristup kod neuroendokrinih tumora |
| 15:15-15:30 |
Miloš Stević |
Radionuclide therapy of NET/Radionuklidna terapija neuroendokrinih tumora |
| 15:30-15:45 |
Branislava Radović |
Radionuclide diagnostics of NET/Radionuklidna dijagnostika neuroendokrinih tumora |
| 15:45-16:00 |
Batool Albalooshi |
Theranostics and tandem therapy using Ac-225 and Lu-177- Dotatate for treatment of NETs/ Dubai experience/Teranostika i tandem terapija Ac-225 i Lu-177- Dotatate u terapiji NET/Iskustva iz Dubaija |
| 16:00-16:15 |
Discussion |
|
| 16:15-16:30 |
Symposium Merck |
”Novine u lečenju pacijenata sa hipotireozom nakon 50 godina iskustva lekom Euthyrox- više doza za bolju preciznost”, “Šta nam donose nove doze leka Euthyrox 88mcg, 112mcg i 137mcg kod pacijenata sa hipotireozom- individualni pristup terapiji”, prof. dr Miloš Žarković |
| 16:35-16:55 |
Symposium Novartis |
Theragnostic in prostate carcinoma/Teranostika u karcinomu prostate |
| 16:55-17:05 |
Coffee break |
| 4 |
Theragnostics in prostate carcinoma |
|
Chairpersons: Vladimir Vukomanović, Miloš Stević
|
| 17:05-17:20 |
Miloš Veljković |
Radionuclide diagnostics of prostate carcinoma/Radionuklidna dijagnostika karcinoma prostate |
| 17:20-17:35 |
Siniša Stanković |
Ga-68 PSMA in diagnosis of prostate carcinoma/Ga-68 PSMA u dijagnostici karcinoma prostate |
| 17:35-17:50 |
Vladimir Vukomanović |
Prostate-Specific Membrane Antigen (PSMA) theranostics for Castration-Resistant Prostate Cancer (CRPC)/PSMA teranostika karcinoma prostate |
| 17:50-18:05 |
Sabina Dizdarević |
Alpha targeted radionuclide treatments in prostate cancer/Alfa radionuklidna terapija u karcinomu prostate |
| 18:05-18:20 |
Sanja Vranješ Djurić |
Production of Tb-161-radiopharmaceuticals in Vinča Institute/Proizvodnja Tb-161-radiofarmaceutika u Institutu Vinča |
| 18:20-18:35 |
Ioannis Koutsikos |
SPECT/CT Imaging of 177Lu-based Radiopharmaceutical Therapies |
| 18:35-18:50 |
Discussion |
|
Friday, October 17, 2025 |
| 5 |
The Achievements in Nuclear Medicine 2024: “Milovan Antić” competition |
|
Chairpersons: Marija Šišić, Slobodanaka Beatović, Drina Janković |
| 9:30-9:45 |
Introduction |
| 9:45-10:00 |
Vladimir Vukomanović |
Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience. Front Endocrinol (Lausanne) 2024 Jan 4; 14:1270421 |
| 10:00-10:15 |
Jasna Mihailović |
Diagnostic performance of F-18 FDG PET/CT in the Detection of Recurrent Colorectal Cancer: Correlation with Biochemical Markers and Conventional Imaging Modalities. J Clin Med 2024 Jan 20; 13(12):3602 |
| 10:20-10:30 |
Ospita specijalna bolnica |
PET/CT dijagnostika |
|
Aida Afgan |
|
| 6 |
Poster presentation |
| 10:30-11:00 |
Chairpersons: Branislava Ilinčić, Isidora Grozdić Milojević, Aleksandar Simić |
| 11:15-11:40 |
Milica Vukadinović, Vladimir Janić |
SRBATOM: Predstavljanje regulatornog okvira u oblasti zaštite od zračenja i primene izvora zračenja u medicini |
| 11:40-12:40 |
Chairpersons: Miloš Stević, Marija Šišić |
Assembly, Serbian Society of Nuclear Medicine and Serbian Medical Society |
| 12:40-13:10 |
Light refreshment |